The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Hoofdauteur: | Jackson, M |
---|---|
Andere auteurs: | Vallis, K |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
2013
|
Onderwerpen: |
Gelijkaardige items
-
Selective targeting of homologous recombination deficiency
door: Zimmer, J
Gepubliceerd in: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
door: Albukhari, A
Gepubliceerd in: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
door: Albukhari, A
Gepubliceerd in: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
door: Potter, M
Gepubliceerd in: (2014) -
Radiopharmaceutical Validation for Clinical Use
door: Charles A. Kunos, et al.
Gepubliceerd in: (2021-03-01)